D.C.’s medical cannabis program sees sales rise in April, driven by new dispensaries
D.C.’s medical cannabis program is showing signs of life after a rough year. Sales in April reached their highest level in nine months, according to a report by the Alcohol Beverage and Cannabis Administration (ABCA). This upswing is likely due in part to the opening of two new medical dispensaries in the District.
The report details a significant increase in manufacturing sales from March to April, potentially more than doubling. This surge coincides with the arrival of the new dispensaries. Patient registration also saw a rise, with Maryland registrations (both temporary and standard) leading the charge. This is particularly interesting considering the dominance of Maryland’s adult-use market since its launch in July 2023.
The coming months will likely see continued growth in the D.C. medical cannabis market. Several new dispensaries are slated to open in May, and their impact will be reflected in the next round of sales metrics.
April 2024 Highlights
- Straight cannabis bud sales (383 lbs) rose again.
- Two inspections were conducted across dispensaries and cultivation centers with no violations found.
- The top state for temporary patient registrations was Virginia followed by Maryland than North Carolina.
- Over 100 new patients registered from Maryland in April.
- All top 3 temporary registrations states (VA, MD, NC) saw a rise in patients.
- 2,100 pounds of cannabis waste was destroyed in April.
- Over 2,569 patient registrations are set to expire by the end of July.
- Manufacturing sales more than doubled from March to April.
- Edible sales dropped by 946.
- The number of vapes sold more than doubled (974).
